AB Bernstein
Jamie Laursen has a diverse work experience that spans over several companies. In 2005, Jamie began their career as a Pharmaceutical Sales Specialist at AstraZeneca, where they worked until 2008. From 2009 to 2010, Jamie worked as an Analyst in Investment Sourcing and Diligence at Avantage Ventures. In 2011, Jamie joined AB Bernstein as the VP of Institutional Equity Research Sales for Asian Equities, and later became the Director of Institutional Equity Research Sales for US Equities in 2015. From 2021 to 2022, Jamie worked in Business Development/Capital Raising for AB Arya, and currently holds the position of Head of North America Business Development for AB Public Alternatives.
Jamie Laursen has a Bachelor of Science degree in BioChemistry from the University of North Carolina at Chapel Hill. Additionally, they have completed an MBA in Finance from the NYU Stern School of Business. Their education history also includes attending the HKUST Business School, and they have previously studied at the Charlotte Country Day School. However, the specific degree and field of study for these two institutions are not provided.
This person is not in the org chart
AB Bernstein
Bernstein is widely recognized as Wall Street's premier sell-side research and brokerage firm, with a global equity trading platform that spans the U.S., Europe, and Asia. Our firm was founded in the U.S. in 1967 and in the U.K. in 1999. Our research and trading capabilities are sought out by leading investment managers around the world, and we are annually ranked at the top of our industry by acknowledged arbiters. In independent surveys of major institutional clients, Bernstein's research is ranked #1 for overall quality, industry knowledge, most trusted, best detailed financial analysis, major company studies, most useful valuation frameworks and best original research. In Institutional Investor’s latest annual client survey, the leading survey by which research analysts in our industry are evaluated, over 90% of our U.S. analysts and the majority of our European Analysts were recognized as among the best in their respective fields – more than any other firm in our industry. We began operations in Hong Kong in 2010, and now cover a range of sectors across Asia. Our European research team is also home to Extel's #1-ranked analyst across Europe. In April 2019 we acquired Autonomous Research, a highly regarded global financial services independent research firm. The combination of Bernstein and Autonomous solidifies our standing as the largest global independent research firm. Research has always been Bernstein's calling card. The brand is defined by our renowned Blackbooks, known for their unbiased, in-depth company and industry forecasts. We have a community of Research Analysts who are acknowledged thought leaders that typically have many years of experience in the industries they cover. Our reputation is for the very highest caliber of independent and disciplined investment and industry analysis. We are a wholly-owned subsidiary of our buy-side parent, AB.